Management of acute pulmonary embolism: a contemporary, risk-tailored approach.
Chalikias
Georgios K
GK
Department of Cardiology, Democritus University of Thrace School of Medicine, Alexandroupolis, Greece.
Tziakas
Dimitrios N
DN
Stakos
Dimitrios A
DA
Konstantinides
Stavros V
SV
D000925:Anticoagulants / Q000008:administration & dosage; D017128:Embolectomy; D050556:Fatty Acid-Binding Proteins / Q000502:physiology; D006439:Hemodynamics; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage; D006801:Humans; D020097:Natriuretic Peptide, Brain / Q000502:physiology; D010446:Peptide Fragments / Q000502:physiology; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D012008:Recurrence; D018570:Risk Assessment; D015912:Thrombolytic Therapy; D014057:Tomography, X-Ray Computed; D014336:Troponin / Q000502:physiology; D014463:Ultrasonography; D016306:Vena Cava Filters; D054556:Venous Thromboembolism / Q000517:prevention & control; D018497:Ventricular Dysfunction, Right / Q000000981:diagnostic imaging / Q000503:physiopathology
D000925:Anticoagulants; D050556:Fatty Acid-Binding Proteins; D006495:Heparin, Low-Molecular-Weight; D010446:Peptide Fragments; D014336:Troponin; C109794:pro-brain natriuretic peptide (1-76); D020097:Natriuretic Peptide, Brain